Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2022-01-07 00:00:00 ET · period of report 2021-12-29 · accession 0001104659-22-002355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-07 | 2021-12-15+ | TGTX | WEISS MICHAEL S | CEO, Pres, Dir | G - Gift | $0.00 | -712.0K | 13.45M | -5% | $0 |
| 2022-01-07 | 2021-12-29 | TGTX | WEISS MICHAEL S | CEO, Pres, Dir | A - Grant | $0.00 | +56.4K | 13.49M | +0.4% | $0 | |
| M | 2022-01-07 | 2022-01-04+ | TGTX | WEISS MICHAEL S | CEO, Pres, Dir | S - Sale | $18.80 | -68.2K | 10.99M | -0.6% | -$1.28M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-12-15 | G | D | 3,000 | $0.00 | 14,145,852 | D | — | — | (F1) Reflects the transfer of shares of TG Therapeutics stock as a bona fide gift to various 501(c)(3) charitable organizations. |
| 2 | Common | COMMON STOCK | 2021-12-29 | A | A | 56,394 | $0.00 | 13,493,246 | D | — | — | (F3) Reflects a grant of restricted shares of common stock of TG Therapeutics in lieu of cash compensation owed to Mr. Weiss for the 2021 fiscal year, which will fully vest on January 1, 2024. |
| 3 | Common | COMMON STOCK | 2021-12-16 | G | D | 9,000 | $0.00 | 13,436,852 | D | — | — | (F1) Reflects the transfer of shares of TG Therapeutics stock as a bona fide gift to various 501(c)(3) charitable organizations. |
| 4 | Common | COMMON STOCK | 2021-12-16 | G | D | 700,000 | $0.00 | 13,445,852 | D | — | — | (F2) Reflects the transfer of shares of TG Therapeutics stock to various trusts for the benefit of Mr. Weiss' dependents. |
| 5 | Common | COMMON STOCK | 2022-01-04 | S | D | 37,549 | $19.20 | 13,455,697 | D | — | — | (F4) In connection with the vesting of 225,000 shares held by Mr. Weiss' dependents on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy tax withholding obligations. Mr. Weiss nor his dependents had any discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. |
| 6 | Common | COMMON STOCK | 2022-01-05 | S | D | 30,671 | $18.31 | 10,988,021 | D | — | — | (F4) In connection with the vesting of 225,000 shares held by Mr. Weiss' dependents on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy tax withholding obligations. Mr. Weiss nor his dependents had any discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. (F5) Includes 2,437,005 shares received as a liquidating distribution from Opus Point Partners, LLC ("Opus"), of which Mr. Weiss was a principal. In prior reports, Mr, Weiss reported beneficial ownership of all 4,874,010 shares held by Opus, even though he only owned 50% of Opus. On December 29, 2021, as part of the dissolution of Opus the shares of TGTX held by Opus were distributed to the underlying Opus owners. As a result of such distribution, the 2,437,005 shares held indirectly by the reporting person are no longer held by the reporting person. |